文献速递前列腺癌

放疗与根治性前列腺切除术后的前列腺癌死亡:全国人群观察性研究

Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study.
PubMed 文献 · Eur Urol · 2017-12-15

单变量分析中放疗组死亡风险更高,但经完全调整后差异显著缩小,低-中危组HR 1.24(95%CI 0.97-1.58),高危组HR 1.03(95%CI 0.81-1.31)。结论认为与既往研究相比,两种治疗后的前列腺癌死亡率差异小得多。

要点

  • 完全调整后低-中危组HR 1.24(95%CI 0.97-1.58),高危组HR 1.03(95%CI 0.81-1.31)。
  • 与既往研究相比,两种治疗后的前列腺癌死亡率差异小得多。

核心结论

  • 与既往研究相比,放疗和根治性前列腺切除术后前列腺癌死亡率差异小得多。
  • 治疗效应与疾病严重程度相关;非随机分配导致混杂仍存在。

研究设计与样本

  • 采用Cox回归模型计算风险比(HR),调整临床T分期、M分期、Gleason分级分组、血清前列腺特异性抗原水平、活检 cores 癌症比例、检测方式、合并症、年龄、教育水平和婚姻状况。
  • 进行左截断的时期分析。

主要发现

  • 单变量分析中,放疗 vs 根治性前列腺切除术的前列腺癌死亡风险:低-中危癌HR 1.82(95%CI 1.53-2.16),高危癌HR 1.57(95%CI 1.33-1.85)。
  • 完全调整的时期分析中,放疗 vs 根治性前列腺切除术的差异减弱:低-中危癌HR 1.24(95%CI 0.97-1.58),高危癌HR 1.03(95%CI 0.81-1.31)。

临床怎么用

  • 原文患者摘要指出:当代放疗与根治性前列腺切除术后的前列腺癌死亡率差异小,提示在选择治疗时应更强调潜在副作用。

局限性

  • 非随机分配导致混杂仍存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are no conclusive results from randomized trials on radiotherapy (RT) versus radical prostatectomy (RP) for prostate cancer. Numerous observational studies have suggested that RP is associated with a lower risk of prostate cancer death, but whether results have been biased due to limited adjustments for confounding factors is unknown. OBJECTIVE: To compare the risk of prostate cancer death after RT versus RP. DESIGN, SETTING, AND PARTICIPANTS: Nationwide population-based observational study of men in the Prostate Cancer data Base Sweden 3.0 who had undergone RT or RP between 1998 and 2012. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Prostate cancer deaths were compared. Hazard ratios (HRs) were calculated in Cox regression models, including clinical T stage, M stage, Gleason grade group, serum levels of prostate-specific antigen, proportion of biopsy cores with cancer, mode of detection, comorbidity, age, educational level, and civil status. Period analysis with left truncation was performed. RESULTS AND LIMITATIONS: Primary treatment was RT or RP for 41 503 men. Treatment effect was associated with disease severity. In univariate analysis of RT versus RP, risk of prostate cancer death was higher after RT-low- and intermediate-risk cancer, HR 1.82 (95% confidence interval [CI]: 1.53-2.16), and high-risk cancer, HR 1.57 (95% CI: 1.33-1.85). After full adjustment in period analysis, this difference between the treatments was attenuated-low- and intermediate-risk cancer, HR 1.24 (95% CI: 0.97-1.58), and high-risk cancer, HR 1.03 (95% CI: 0.81-1.31). Confounding remained due to nonrandom allocation to treatment. CONCLUSIONS: In comparison with previous studies, the difference in prostate cancer mortality after RT and RP was much smaller. PATIENT SUMMARY: The difference in prostate cancer mortality after contemporary radiotherapy and radical prostatectomy was small in contrast to previous studies, indicating that potential side effects should be more emphasized when selecting treatment.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Robinson D, Garmo H, Lissbrant IF, et al. Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study. Eur Urol. 2017. PMID: 29254629. doi:10.1016/j.eururo.2017.11.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。